Both Johnson & Johnson JNJ and Merck MRK are leading U.S. healthcare conglomerates — blue-chip pharmaceutical companies with ...

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both. The popular research ...

Recently, a federal judge ruled that a Johnson & Johnson subsidiary must pay $442 million in damages after a jury concluded ...

Johnson & Johnson (NYSE: JNJ) announced today that Daniel Pinto, President, JPMorganChase, has been elected to its Board of ...

Johnson & Johnson (NYSE:JNJ) recently announced promising Phase 1 study results for Pasritamig, a novel antibody for advanced ...

Johnson & Johnson (NYSE: JNJ) announced today that it elected JPMorganChase President Daniel Pinto to its board of directors.

Early Phase I results for JNJ-79635322 demonstrated an 86.1% overall response rate in heavily pretreated multiple myeloma ...

Johnson & Johnson denied wrongdoing after a conservative watchdog group accused the company of violating federal equal ...

Ethicon 4000 features proprietary 3D staple technology, a redesigned end effector and streamlined reload options. Johnson & ...

Johnson & Johnson shows strong profitability and solid value, but faces growth uncertainty, legal risks, and pricing ...

Johnson & Johnson (NYSE:JNJ) recently announced the election of Daniel Pinto, a seasoned executive with extensive experience, to its Board of Directors, potentially reinforcing its strategic oversight ...

Johnson & Johnson has elected JPMorganChase's President Daniel Pinto to its Board of Directors.Pinto is a prominent business ...